Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830693) titled 'Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A' on Sept. 15.

Study Type: Observational

Primary Sponsor: Nantes University Hospital

Condition: Hemophilia A Patient

Intervention: Other: Study questionnaires

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2027

Target Sample Size: 553

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/study/NCT07830693

Published by HT Digital Content Services with permission from Health Daily Digest....